Stirling Anglian PharmaceuticalsStirling Anglian PharmaceuticalsStirling Anglian PharmaceuticalsStirling Anglian Pharmaceuticals
  • Home
  • Our Products
    • Acepiro®
    • theiCal-D3®
    • Stirlescent®
    • CosmoCol®
    • CosmoCol Half®
    • CosmoCol Paediatric®
    • Diclofenac Sodium 3% Gel
    • Calcipotriol 0.005% / Betamethasone Dipropionate 0.05% Gel
  • Corporate Responsibility
    • Patient Safety
    • Transparency Disclosures
    • Social Responsibility
    • Modern Slavery Statement
    • Equality, Diversity & Inclusion
    • Corporate Policies
  • Sustainability
  • Partners
  • Contact
✕

Calcipotriol 0.005% / Betamethasone dipropionate 0.05% Gel

Information for Patients

  • Calcipotriol/Betamethasone 50 micrograms/g + 0.5 mg/g Gel - Patient Information Leaflet
  • Calcipotriol/Betamethasone 50 micrograms/g + 0.5 mg/g Gel - Summary of Product Characteristics
Information For Healthcare Professionals
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel

Patient links and organisations

  • Navigating Change in UK Psoriatic Care
  • Psoriatic Disease UK | The Patient-led Psoriasis and Psoriatic Arthritis Charity
  • Psoriatic Arthritis: Symptoms, causes and treatment | Arthritis UK
  • About Psoriasis
© 2026 Stirling Anglian Pharmaceuticals Ltd
Registered in Scotland. Company No. SC453258
26-SAP-007 v1.0 - April 2026
Terms & Conditions | Privacy Policy
Website by
Website by
Calcipotriol 0.005% / Betamethasone Dipropionate 0.05% Gel – Information for Patients
This website uses cookies to improve your experience.
Privacy Policy

Information for Healthcare Professionals

The information on this page is intended for healthcare professionals only.

You are leaving our website

The link you have requested is on an external website.

Continue Cancel